Development of a risk prediction model for gastrointestinal adverse events associated with semaglutide administration in patients with type 2 diabetes mellitus

ObjectiveThis study aims to identify the risk factors associated with gastrointestinal adverse events induced by semaglutide in patients with type 2 diabetes mellitus (T2DM) and to develop a predictive risk model.MethodsA total of 215 patients with T2DM admitted to our hospital between June 2022 and...

書誌詳細
出版年:	Frontiers in Endocrinology
主要な著者:	Deyong Yue, Xuesheng Hua, Ling Zhu, Jun Wang, Lihua Gu, Zhengxia Yuan, Wenle Jian, Yirong Chen, Guoliang Meng
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-11-01
主題:	semaglutide type 2 diabetes mellitus gastrointestinal adverse events risk prediction model alcohol α-glucosidase inhibitors
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1684395/full

類似資料

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
著者:: Kaibin Niu, 等
出版事項: (2024-06-01)

Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration
著者:: Evgenia Koureta, 等
出版事項: (2024-02-01)

Case Report: Semaglutide-associated depression: a report of two cases
著者:: Jia-Rui Li, 等
出版事項: (2023-08-01)

Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data
著者:: Marine Massy, 等
出版事項: (2025-04-01)

Adherence and treatment discontinuation of oral semaglutide and once‐weekly semaglutide injection at 12 month follow‐up: Japanese real‐world data
著者:: Takeshi Horii, 等
出版事項: (2024-11-01)

Semaglutide in the Real World: Attitudes of the Population
著者:: Doris Rušić, 等
出版事項: (2025-09-01)

Semaglutide and weight management in the Arab countries: Focus on the United Arab Emirates
著者:: Sabina Semiz
出版事項: (2025-12-01)

The craze with semaglutide
著者:: Ruby Dhar, 等
出版事項: (2024-06-01)

Dose-dependent erythema nodosum after initiation of semaglutide
著者:: Jeffrey Sobieraj, MD, 等
出版事項: (2024-05-01)

Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
著者:: Rafael Simó, 等
出版事項: (2021-07-01)

Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years
著者:: Marwan Sabbagh, 等
出版事項: (2025-04-01)

Semaglutide’s dilemma: A lifesaver with a price?
著者:: Niladri Dingal
出版事項: (2025-05-01)

Spotlight on the Mechanism of Action of Semaglutide
著者:: Ilias Papakonstantinou, 等
出版事項: (2024-12-01)

From Diabetes to Weight Loss: The Problems with Semaglutide's Expanded Use
著者:: Rawan Othman
出版事項: (2025-08-01)

Alopecia areata following semaglutide treatment for weight loss: A case report
著者:: Wasan S. Alzahrani, MBBS, 等
出版事項: (2025-09-01)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
著者:: Shu Niu, 等
出版事項: (2022-12-01)

Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration
著者:: Jing Zhang, 等
出版事項: (2024-10-01)

Semaglutide in the Treatment of Diabetes and Associated Obesity
著者:: Rafal Makuch, 等
出版事項: (2024-06-01)

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
著者:: Xiaoyi Chen, 等
出版事項: (2023-03-01)

A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
著者:: Yikuan Du, 等
出版事項: (2024-10-01)

Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan
著者:: Mohamed Hassanein, 等
出版事項: (2022-12-01)

The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide
著者:: Tovi Shapira-Furman, 等
出版事項: (2024-08-01)

Evaluating gastrointestinal side effects and discontinuation rates of semaglutide in routine clinical practice: A prospective observational study.
著者:: Monika Patel Kodela, 等
出版事項: (2025-09-01)

Contractile Effects of Semaglutide in the Human Atrium
著者:: Joachim Neumann, 等
出版事項: (2024-08-01)

Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting
著者:: Tao Zhao, 等
出版事項: (2025-04-01)

Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
著者:: Pan X, 等
出版事項: (2022-11-01)

Semaglutide: an emerging treatment option for patients with obesity related HFpEF
著者:: Sanya Ashraf Khaskheli, 等
出版事項: (2024-08-01)

Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes
著者:: Mohamad Suki, 等
出版事項: (2025-07-01)

Semaglutide and weight loss – a concern for diabetics and pharmaceuticals
著者:: Bushra Admani, 等
出版事項: (2024-05-01)

Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients — Real World Study
著者:: Balcázar-Valencia CM, 等
出版事項: (2024-04-01)

FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trialResearch in context
著者:: Vincent Wai-Sun Wong, 等
出版事項: (2023-12-01)

Reversible bilateral central scotoma under scotopic conditions associated with oral semaglutide
著者:: Peter Bracha, 等
出版事項: (2024-12-01)

Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
著者:: Chen X, 等
出版事項: (2022-11-01)

Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice
著者:: Yang Y, 等
出版事項: (2024-03-01)

Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
著者:: Takahiro Iijima, 等
出版事項: (2023-06-01)

Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial
著者:: Jelena Petković-Dabić, 等
出版事項: (2025-01-01)

Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study
著者:: Taeang Arai, 等
出版事項: (2022-07-01)

Effectiveness and Side Effect Incidence in a Real-World Digital Weight-Loss Service Using Compounded Semaglutide: A Retrospective Comparative Study
著者:: Louis Talay, 等
出版事項: (2024-10-01)

Effects of semaglutide on metabolism and gut microbiota in high-fat diet-induced obese mice
著者:: Luyan Sun, 等
出版事項: (2025-06-01)

Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network
著者:: David García-Vega, 等
出版事項: (2024-01-01)